BIIB position history
The shares of Biogen (BIIB) that Patient Capital Management, LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q1: 217,887 shares, $47M, 2.3% of portfolio, New
- 2024 Q2: 257,269 shares, $60M, 3.2% of portfolio, Add +18.1%
- 2024 Q3: 255,942 shares, $50M, 2.4% of portfolio, Reduce −0.5%
- 2024 Q4: 413,960 shares, $63M, 2.9% of portfolio, Add +61.7%
- 2025 Q1: 455,605 shares, $62M, 3.2% of portfolio, Add +10.1%
- 2025 Q2: 320,466 shares, $40M, 1.8% of portfolio, Reduce −29.7%
- 2025 Q3: 396,649 shares, $56M, 2.2% of portfolio, Add +23.8%
- 2025 Q4: 576,352 shares, $101M, 3.9% of portfolio, Add +45.3%
- 2026 Q1: 379,741 shares, $70M, 2.5% of portfolio, Reduce −34.1%
- 2026 Q2: 283,697 shares, $61M, 2.0% of portfolio, Reduce −25.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|